Agilon Health Inc (AGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -260,101 | -262,803 | -106,864 | -406,787 | -60,052 |
| Depreciation Amortization | 24,463 | 20,161 | 13,772 | 14,670 | 14,099 |
| Income taxes - deferred | N/A | N/A | 532 | -3,231 | -2,809 |
| Accounts receivable | -74,580 | -460,365 | -204,167 | -149,041 | -59,381 |
| Accounts payable and accrued liabilities | 193,941 | 441,500 | 107,713 | 76,339 | 42,383 |
| Other Working Capital | 130,589 | -10,067 | -59,435 | -55,025 | 6,472 |
| Other Operating Activity | -72,089 | 115,375 | 117,641 | 374,916 | 6,084 |
| Operating Cash Flow | $-57,777 | $-156,199 | $-130,808 | $-148,159 | $-53,204 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13,251 | -15,830 | -15,426 | -6,564 | -1,775 |
| Net Acquisitions | N/A | 2,193 | 500 | -1,344 | 26,205 |
| Purchase Of Investment | -25,739 | -134,185 | -464,775 | -82,831 | -3,847 |
| Sale Of Investment | 206,915 | 164,040 | 52,548 | 7,095 | 2,058 |
| Purchase Sale Intangibles | -28,034 | -14,985 | -17,235 | -6,862 | -575 |
| Other Investing Activity | -28,034 | -60,237 | -17,235 | -6,862 | -575 |
| Investing Cash Flow | $139,891 | $-44,019 | $-444,388 | $-90,506 | $22,066 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 100,000 | N/A |
| Debt Repayment | -3,750 | -5,000 | -5,000 | -119,899 | -3,041 |
| Common Stock Issued | 1,167 | 11,867 | 33,056 | 1,189,028 | 34,404 |
| Common Stock Repurchased | N/A | -200,000 | N/A | N/A | -6,742 |
| Other Financing Activity | 0 | 0 | 0 | -14,739 | 0 |
| Financing Cash Flow | $-2,583 | $-193,133 | $28,056 | $1,154,390 | $24,621 |
| Beginning Cash Position | 114,329 | 507,680 | 1,054,820 | 139,095 | 145,612 |
| End Cash Position | 193,860 | 114,329 | 507,680 | 1,054,820 | 139,095 |
| Net Cash Flow | $79,531 | $-393,351 | $-547,140 | $915,725 | $-6,517 |
| Free Cash Flow | |||||
| Operating Cash Flow | -57,777 | -156,199 | -130,808 | -148,159 | -53,204 |
| Capital Expenditure | -13,251 | -15,830 | -15,426 | -6,564 | -1,775 |
| Free Cash Flow | -71,028 | -172,029 | -146,234 | -154,723 | -54,979 |